Global Lab Automation for In-vitro Diagnostics Market, By Equipment (Automated Plate Handler, Automated Liquid Handler, Robotic Arm, Automated Storage and Retrieval System, and Analyser), End User (Academic, Laboratory, and Other End Users) , Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Lab Automation for In-vitro Diagnostics Market
Data Bridge Market Research analyses that the lab automation for in-vitro diagnostics market will grow at a CAGR of 6.32% and account for USD 7,501.35 million by 2028 and in the forecast period of 2021-2028.
Lab automation is the process in which specimen processing equipment is used to perform clinical research. This procedure is carried out to develop new technology to improve productivity and decline the time cycles. In-vitro diagnostics is used in various environments, including laboratories, clinics, educational institutes and diagnostic centres, or homes.
The increase in demand for the lab automation owing to the high accuracy and reproducibility, is one of the major factors driving the growth of lab automation for the in-vitro diagnostics market. The rise in research and development activities in the pharmaceutical industries and growth in demand for process automation for food safety accelerate the lab automation for in-vitro diagnostics market growth. The rise in adoption of these systems due to the standardization of workflows and stringent regulatory control in the healthcare industry further influences the growth of the lab automation for in-vitro diagnostics market. . Furthermore, integration of AI and analytical tools in laboratory workflows extends profitable opportunities to the lab automation market players in the forecast period of 2021 to 2028.
However, lack of skilled laboratory professionals and the limited feasibility of technology integration in analytical labs will challenge and hamper the market of lab automation for in-vitro diagnostics.
This lab automation for in-vitro diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on lab automation for in-vitro diagnostics market contact data bridge market research for an analyst brief, our team will help you take an informed market decision to achieve market growth.
Global Lab Automation for In-vitro Diagnostics Market Scope and Market Size
The lab automation for in-vitro diagnostics market is segmented on the basis of equipment and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of equipment, the lab automation for in-vitro diagnostics market is segmented into, automated plate handler, automated liquid handler, robotic arm, automated storage and retrieval system, and analyser.
- On the basis of end-user, the lab automation for in-vitro diagnostics market is segmented into, academic, laboratory, and other end users.
Lab Automation for In-vitro Diagnostics Market Country Level Analysis
The lab automation for in-vitro diagnostics market is analysed and market size insights and trends are provided by country, equipment and end-user as referenced above.
The countries covered in the lab automation for in-vitro diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the lab automation for in-vitro diagnostics market due the presence of large pharmaceutical companies and rapid surge in investment in drug discovery and genomics sector. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increase in development of the novel technologies, rapid rise in population and constant technological advancements.
The country section of the lab automation for in-vitro diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The lab automation for in-vitro diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for lab automation for in-vitro diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lab automation for in-vitro diagnostics market. The data is available for historic period 2020 to 2028.
Competitive Landscape and Lab Automation for In-vitro Diagnostics Market Share Analysis
The lab automation for in-vitro diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to L lab automation for in-vitro diagnostics market.
The major players covered in the lab automation for in-vitro diagnostics market report are, Beckman Coulter, Inc., Tecan Trading AG, Perkinelmer, Inc., Danaher, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen, F. Hoffmann-La Roche Ltd, Siemens AG, Hamilton Company, Abbott, Aurora Biomed Inc., BD, BioTek Instruments, Inc., Brooks Automation, Inc., Cerner Corporation, Biomérieux SA, Eppendorf AG, LabVantage Solutions, Inc., LabWare, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
